Evidence map›Paper›PMID 25879044›Full record

ArticleJournal of immunology research2015

MBL2 genotypes and their associations with MBL levels and NICU morbidity in a cohort of Greek neonates.

Matthaios Speletas, Antonios Gounaris, Eirini Sevdali, Maria Kompoti, Katerina Konstantinidi, Rozeta Sokou, Elena Tsitsami, Anastasios E Germenis

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Stressful Newborn Memories: Pre-Conceptual,Frontiers in psychiatry · 2019
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Matthaios SpeletasDepartment of Immunology & Histocompatibility, School of Health Sciences, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, Biopolis 3, 41500 Larissa, Greece.ORCID 0000-0003-1287-7734
Antonios GounarisNeonatal Intensive Care Unit, School of Health Sciences, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, Biopolis 3, 41500 Larissa, Greece ; Neonatal Intensive Care Unit, General Hospital of Nikea "Agios Panteleimon", 11634 Athens, Greece.
Eirini SevdaliDepartment of Immunology & Histocompatibility, School of Health Sciences, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, Biopolis 3, 41500 Larissa, Greece.
Maria KompotiIntensive Care Unit, Thriassion General Hospital of Eleusis, 19600 Athens, Greece.
Katerina KonstantinidiNeonatal Intensive Care Unit, General Hospital of Nikea "Agios Panteleimon", 11634 Athens, Greece.
Rozeta SokouNeonatal Intensive Care Unit, General Hospital of Nikea "Agios Panteleimon", 11634 Athens, Greece.
Elena TsitsamiDepartment of Immunology & Histocompatibility, School of Health Sciences, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, Biopolis 3, 41500 Larissa, Greece.
Anastasios E GermenisDepartment of Immunology & Histocompatibility, School of Health Sciences, Faculty of Medicine, University Hospital of Larissa, University of Thessaly, Biopolis 3, 41500 Larissa, Greece.
University Hospital of Larissa · GRGeneral Hospital of Nikea · GRThriasio General Hospital of Elefsina · GRUniversity of Thessaly · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to assess the frequency of MBL2 genotypes and their associations with MBL levels and various morbidities of a neonatal intensive care unit (NICU). One hundred and thirty-four (134) NICU (83 term and 51 preterm) and 150 healthy neonates were enrolled in the study. MBL2 genotype and MBL serum levels at birth were determined prospectively by PCR-RFLP-sequencing and enzyme-linked immunosorbent assay, respectively. NICU neonates displayed significantly lower MBL serum levels compared to healthy ones. MBL deficiency, defined as the low MBL2 expression group (XA/O and O/O), was significantly associated with an increased risk of respiratory morbidity, especially transient tachypnea of the newborn and respiratory distress syndrome (RDS). Moreover, an increase of 100 ng/mL of serum MBL levels decreases by 5% the risk of total respiratory morbidity and by 7% the risk of RDS, after correction for prematurity and sex and regardless of the presence of infections. Our study further supports the notion that neonates with MBL deficiency and low MBL serum levels at birth may be at higher risk of developing severe respiratory complications.

Indexed as

C-Reactive ProteinFemaleGreeceHaplotypesHumansInfant, NewbornInfant, PrematureIntensive Care, NeonatalMaleMannose-Binding LectinPolymorphism, Single NucleotidePremature BirthPromoter Regions, GeneticRespiratory Distress Syndrome, NewbornC-Reactive ProteinMannose-Binding LectinMBL2 protein, human

Identifiers

PMID25879044
PMCPMC4387979
OpenAlexW2078519346

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.